Literature DB >> 9228120

Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.

J R Jackson1, J A Minton, M L Ho, N Wei, J D Winkler.   

Abstract

OBJECTIVE: To study the mechanism by which hypoxia and inflammatory cytokines mediate angiogenesis in the rheumatoid pannus through their effects on the fibroblast-like type B synoviocyte, the major cell type of normal synovia.
METHODS: Fibroblasts were prepared from synovial tissue of healthy and diseased individuals, and cultured in the presence of various stimuli. The expression of vascular endothelial growth factor (VEGF) was assessed by ELISA and reverse transcription polymerase chain reaction.
RESULTS: Unlike normal fibroblasts, synovial fibroblasts from rheumatoid arthritis (RA) and osteoarthritis constitutively secreted significant levels of VEGF, which is known to act directly on endothelial cells. VEGF secretion was further inducible by both hypoxia and interleukin 1beta (IL-1beta) and these increases were additive. In contrast, tumor necrosis factor alpha was unable to induce VEGF expression.
CONCLUSION: Under hypoxia or IL-1 stimulation, conditions common to the inflamed synovium, type B synoviocytes secrete increased levels of VEGF, which is likely to act on nearby endothelia, promoting angiogenesis. The constitutive expression of VEGF in rheumatoid synovial fibroblasts may reflect an altered phenotype involved in the pathology of RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228120

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  48 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

4.  Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy.

Authors:  R A De Boer; R H Henning; R A Tio; Y M Pinto; R M H J Brouwer; R J Ploeg; M Böhm; W H Van Gilst; D J Van Veldhuisen
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 5.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

6.  The effect of local anaesthetics on synoviocytes: a possible indirect mechanism of chondrolysis.

Authors:  Hillary J Braun; Benjamin T Busfield; Hyeon Joo Kim; Gaetano J Scuderi; Jason L Dragoo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-21       Impact factor: 4.342

Review 7.  [Patellofemoral pain].

Authors:  V Sanchis-Alfonso
Journal:  Orthopade       Date:  2008-09       Impact factor: 1.087

Review 8.  Augmenting tendon and ligament repair with platelet-rich plasma (PRP).

Authors:  Ting Yuan; Chang-Qing Zhang; James H-C Wang
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

9.  Multiple CD11c+ cells collaboratively express IL-1β to modulate stromal vascular endothelial growth factor and lymph node vascular-stromal growth.

Authors:  Fairouz Benahmed; Susan Chyou; Dragos Dasoveanu; Jingfeng Chen; Varsha Kumar; Yoichiro Iwakura; Theresa T Lu
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

Review 10.  Graft remodeling and ligamentization after cruciate ligament reconstruction.

Authors:  S U Scheffler; F N Unterhauser; A Weiler
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-05-31       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.